Lumos Pharma, Inc. (LUMO)

Lumos Pharma Revenue

In the year 2023, Lumos Pharma had annual revenue of $2.05M with 34.67% growth. Revenue in the quarter ending December 31, 2023 was $826.00K with 61.33% year-over-year growth.

• Revenue (ttm): $2.05M
• Revenue Growth: +34.67%
• P/S Ratio: 11.94
• Revenue / Employee: $62,152
• Employees: 33
• Market Cap: 24.48M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.05M	528.00K	34.67%
Dec 31, 2022	1.52M	1.29M	562.17%
Dec 31, 2021	230.00K	62.00K	36.90%
Dec 31, 2020	168.00K	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	12.47M	-16.24M	-56.55%
Dec 31, 2017	28.71M	-7.06M	-19.73%
Dec 31, 2016	35.77M	-32.73M	-47.78%
Dec 31, 2015	68.50M	-104.09M	-60.31%
Dec 31, 2014	172.59M	171.50M	15,690.67%
Dec 31, 2013	1.09M	-594.00K	-35.21%
Dec 31, 2012	1.69M	-185.00K	-9.88%
Dec 31, 2011	1.87M	-207.00K	-9.96%
Dec 31, 2010	2.08M	1.15M	122.59%
Dec 31, 2009	934.00K	301.00K	47.55%
Dec 31, 2008	633.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.